Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Listen to Startland’s bonkers SXSW experience
Virtual reality, smart cities and a whole lot of habaneros. There was more to Startland’s adventure to Austin, Texas, for South by Southwest — but those three items were certainly some memorable highlights. The Startland team spent five nights in Austin, taking in the insanity that is SXSW. We saw a ton of incredible technology — virtual…
Kansas City named a finalist for $50M award at SXSW
Austin, Texas — Kansas City is a finalist for a $50 million award that could transform its transportation system. U.S. Secretary of Transportation Anthony Foxx announced on Saturday at South by Southwest that the City of Fountains was among seven finalists in the “Beyond Traffic, Smart City Challenge.” The challenge aims to help mid-sized cities…
Startland News hits the road to SXSW
Load up the clown car — Startland is going down south. Kansas City’s source for entrepreneurial and tech news is venturing to arguably the nation’s top conference for innovative ideas: South-by-Southwest Interactive. The Startland team has a jam-packed schedule while at SXSW, mingling with techies, early-adopters and thousands of Austonians. Make sure you follow along on…
The WTF Series: Triple constraint
One of the hardest parts of software development is managing stakeholder expectations. Of course, everyone wants as much as they can get, as fast as possible, for the lowest price. Why wouldn’t you? The problem is that most programmers get frustrated when a stakeholder asks for too much too fast, and don’t know how…